IRIS
TISONE, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 79.996
AS - Asia 8.940
EU - Europa 5.848
SA - Sud America 1.412
AF - Africa 102
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 15
Totale 96.333
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 79.804
SG - Singapore 4.735
CN - Cina 1.817
BR - Brasile 1.185
HK - Hong Kong 1.150
UA - Ucraina 1.069
DE - Germania 987
IE - Irlanda 822
IT - Italia 796
RU - Federazione Russa 581
GB - Regno Unito 389
VN - Vietnam 377
SE - Svezia 354
FI - Finlandia 281
KR - Corea 281
FR - Francia 162
IN - India 119
CA - Canada 102
JP - Giappone 94
NL - Olanda 91
AR - Argentina 86
PL - Polonia 81
AT - Austria 68
ID - Indonesia 61
TR - Turchia 61
MX - Messico 60
BD - Bangladesh 43
EC - Ecuador 43
ZA - Sudafrica 39
IQ - Iraq 34
ES - Italia 32
BE - Belgio 29
CO - Colombia 24
CZ - Repubblica Ceca 24
CL - Cile 21
EG - Egitto 21
UZ - Uzbekistan 17
CH - Svizzera 15
PY - Paraguay 15
EU - Europa 14
PK - Pakistan 14
AU - Australia 13
AE - Emirati Arabi Uniti 11
IR - Iran 11
PE - Perù 11
SA - Arabia Saudita 11
VE - Venezuela 11
GR - Grecia 10
IL - Israele 10
KZ - Kazakistan 10
UY - Uruguay 10
AZ - Azerbaigian 9
JO - Giordania 9
KE - Kenya 9
KG - Kirghizistan 9
RO - Romania 9
TN - Tunisia 9
DO - Repubblica Dominicana 7
LT - Lituania 7
MA - Marocco 7
MY - Malesia 6
OM - Oman 6
TT - Trinidad e Tobago 6
MD - Moldavia 5
NO - Norvegia 5
PH - Filippine 5
TH - Thailandia 5
BG - Bulgaria 4
BO - Bolivia 4
HN - Honduras 4
JM - Giamaica 4
KH - Cambogia 4
KW - Kuwait 4
NG - Nigeria 4
NP - Nepal 4
TM - Turkmenistan 4
A1 - Anonimo 3
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
BY - Bielorussia 3
DM - Dominica 3
DZ - Algeria 3
LV - Lettonia 3
MK - Macedonia 3
QA - Qatar 3
AM - Armenia 2
DK - Danimarca 2
HU - Ungheria 2
LB - Libano 2
LU - Lussemburgo 2
ML - Mali 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
SN - Senegal 2
SR - Suriname 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
Totale 96.312
Salva come PNG Salva come JPEG
Città #
Woodbridge 22.750
Wilmington 21.188
Houston 18.846
Fairfield 2.243
Singapore 2.082
Ann Arbor 1.946
Ashburn 1.257
Chandler 1.185
Hong Kong 1.142
Jacksonville 967
Seattle 958
Cambridge 834
Dublin 803
Beijing 795
New York 725
Medford 605
Santa Clara 410
Dearborn 330
Los Angeles 292
The Dalles 290
Lawrence 284
Zhengzhou 283
Rome 277
Buffalo 188
Mülheim 172
San Diego 146
São Paulo 130
Ho Chi Minh City 124
Moscow 123
Council Bluffs 118
Menlo Park 95
Dallas 91
Milan 88
Hangzhou 84
Chicago 81
Munich 76
Hanoi 72
Shanghai 62
London 59
Jersey City 58
Nuremberg 58
San Mateo 54
Creede 51
Redwood City 51
Palo Alto 49
Tokyo 49
University Park 49
Guangzhou 47
Mountain View 46
Montreal 43
Rio de Janeiro 42
Jakarta 40
Falls Church 39
Saint Petersburg 39
Boardman 38
Denver 38
Nanjing 38
Verona 38
Warsaw 38
Atlanta 37
Norwalk 37
Redondo Beach 37
Chennai 35
Phoenix 35
San Francisco 33
Hefei 32
Johannesburg 32
Stockholm 31
Vienna 31
Brooklyn 30
Kraków 30
Seoul 29
Frankfurt am Main 28
Helsinki 28
Engelhard 27
Lappeenranta 26
Poplar 26
Kunming 25
Turku 25
Belo Horizonte 24
Brussels 24
Columbus 24
Manchester 24
Salt Lake City 24
Toronto 24
Amsterdam 23
Mexico City 23
Orem 22
Brasília 21
Curitiba 20
Quito 18
Ankara 16
Haiphong 15
Nanchang 15
Bologna 13
Porto Alegre 13
Pune 13
Tashkent 13
Turin 13
Chengdu 12
Totale 84.114
Salva come PNG Salva come JPEG
Nome #
Hepatitis C reinfection after liver transplantation in relation to virus genotype 588
Maintenance ribavirin monotherapy delays fibrosis progression in liver transplant recipients with recurrent hepatitis C at high risk of progression 557
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 552
Tauroursodeoxycholate reduces ischemic damage in human allografts: a biochemical and ultrastructural study 538
Successful management of a same-day emergency delivery and liver transplant in a 27 weeks pregnant woman with fulminant hepatic failure. 493
Re-Evaluation of the Role of Antifibrinolytic Therapy with Lysine Analogs in Liver Transplantation in The Post-Aprotinin Era 485
Recurrence of insulin resistant metabolic syndrome following liver transplantation 484
HCV-RNA quantification in liver bioptic samples and extrahepatic compartments, using the abbott RealTime HCV assay 483
Cyclosporine A versus tacrolimus monotherapy. Comparison on bile lipids in the first 3 months after liver transplant in humans 481
Graft failure due to hemolytic uremic syndrome recurrence 477
Downstaging disease in patients with hepatocellular carcinoma outside up-to-seven criteria: Strategies using degradable starch microspheres transcatheter arterial chemo-embolization 477
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C. 475
Operational tolerance in clinical liver transplantation: emerging developments. 470
Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients 469
Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques. 467
Deep vein thrombosis as debut of cytomegalovirus infection associated with type ii cryoglobulinemia, with antierythrocyte specificity in a kidney transplant recipient: A case report 467
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. 465
Primary yolk sac tumor of the liver: incidental finding in a patient transplanted for hepatocellular carcinoma 464
Bronchobiliary fistula treated by self-expanding ePTFE-covered nitinol stent-graft 463
Relationship between GH/IGF-1 Axis, graft recovery, and early survival in patients undergoing liver transplantation 462
Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: Two case reports 461
Role of MRI with hepatospecific contrast agent in the identification and characterization of focal liver lesions: pathological correlation in explanted livers 460
Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation. 457
Correlation between liver fibrosis and inflammation in patients transplanted for HCV liver disease 456
Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence 454
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 450
Bronchobiliary fistula treated by self-expanding ePTFE-covered nitinol stent-graft. 449
Infectious complications in renal transplant recipients 446
Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients 446
Ribavirin increases mitogen- and antigen-induced expression of CD40L on CD4+ T cells in vivo. 443
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting. 442
Is nephrectomy indicated in uremic patients with ADPKD waiting for transplant? 441
Liver transplantation for Wilson's disease: The burden of neurological and psychiatric disorders 440
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study 440
Marginal donors in liver transplantation. 439
Steroid-free immunosuppression after liver transplantation does not increase the risk of graft fibrosis. 437
Interposition of the right colic angle between the liver and thoracic wall: an unusual cause of massive rectal bleeding following percutaneous biopsy in a liver transplant recipient. 436
Clinical and neurophysiological evidence of polyneuropathy in liver transplant candidates: preliminary report. 435
596 435
Leptin attenuates ischemia-reperfusion injury in the rat liver. 435
Conversion to rapamycin immunosuppression for malignancy after kidney transplantation 430
Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension 429
Liver abscess caused by foreign body ingestion 429
Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial. 428
Flow cytometric analysis of antidonor-specific antibodies in liver transplant. 428
Assembly of biliary lipids in native hepatic bile after orthotopic liver transplantation: a biochemical and ultra-structural study in humans 427
Management of spermatic cord liposarcoma in renal transplant recipients: case report 427
Low-dose hepatitis B immunoglobulin given "on demand" in combination with lamivudine: a highly cost-effective approach to prevent recurrent hepatitis B virus infection in the long-term follow-up after liver transplantation. 427
Quality of life and long-term follow-up after kidney transplantation: a 30-year clinical study. 427
Graft failure due to hemolytic uremic syndrome recurrence 427
Combined liver transplantation and sleeve gastrectomy for end-stage liver disease in a bariatric patient: First European case-report 427
A randomized trial of everolimus and low-dose cyclosporine in renal transplantation: With or without steroids? 427
Interposition of the right colic angle between the liver and thoracic wall: An unusual cause of massive rectal bleeding following percutaneous biopsy in a liver transplant recipient 426
Phase I clinical trial with the AMC-bioartificial liver. 425
10-28 year follow-up in 23 patients with kideny traansplantation: immunosuppressive therapy, survival and complications 425
Immunosuppression-Free Liver Transplantation 425
Complete hbv prophylaxis withdrawal in HBsAg-positive liver transplant recipients after long-term minimal immunosuppression 425
Use of mycophenolate mofetil in liver transplantation: a literature review. 424
Retrospective analysis of 30 patients who underwent liver transplantation without use of steroids 424
Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia. 422
Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C 421
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 421
Intragastric balloon followed by biliopancreatic diversion in a liver transplant recipient: a case report. 419
Extended double-dosage HBV vaccination after liver transplantation is ineffective, in the absence of lamivudine and prior wash-out of human Hepatitis B immunoglobulins 419
Ureteral obstruction in 140 renal transplant patients: preventions and treatment 418
Raised hematocrit--a contributing factor to hepatic artery thrombosis following liver transplantation. 417
Percutaneous laser ablation of hepatocellular carcinoma in patients with liver cirrhosis awaiting liver transplantation. 417
Gravity perfusion versus high-pressure perfusion in kidney transplantation: results from a prospective randomized study. 416
Surgical versus percutaneous technique for veno-venous bypass during orthotopic liver transplantation: a prospective randomized study. 415
Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. 415
Reduced acute rejection and side effects with neoral in liver transplantation. 415
Extended HBV vaccination in liver transplant recipients for HBV-related cirrhosis: report of two successful cases. 414
Multiparameter immune profiling of operational tolerance in liver transplantation. 414
Prospective study of switch from cyclosporine to tacrolimus for fibroadenomas of the breast in kidney transplantation. 414
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C 412
Spontaneous resolution of severe acute rejection in liver transplantation. 412
Liver transplantation in the presence of portal vein thrombosis: report from a single center. 411
Liver transplantation for end-stage liver disease related to viral hepatitis 411
Liver transplantation in primary hepatic carcinoid tumor: case report and literature review. 410
Metabolic findings after liver transplantation within a randomised trial with or without steroids 410
Qualitative patterns of biliary bile acids affect cyclosporine intestinal absorption in liver transplant recipients 409
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting 408
Non-transplant surgical approach to liver-based hereditary haemorrhagic telangiectasia: a first report 408
Sequential changes in serum and biliary bile acids after liver transplantation 408
Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. 408
One-year pilot study on tauroursodeoxycholic acid as an adjuvant treatment after liver transplantation 407
Kidney transplantation and pregnancy. 407
Is donor age a risk factor for poor graft function after orthotopic liver transplantation? 406
2.0 J Ti:sapphire laser oscillator. 406
Characterization of γδ T cell subsets in organ transplantation. 406
Spontaneous resolution of severe acute rejection in liver transplantation 406
Clinical Significance of de novo production of HLA of donor-specific antibodies in kidney transplantation. 405
13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation 405
The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up 404
Side-to-side caval anastomosis in a patient receiving a liver graft from a marginal donor with situs inversus totalis 404
Average results and follow-up in 11 over-60 years of age kidney transplanted patients 403
Surgical antibiotic prophylaxis after renal transplantation: time to reconsider. 403
13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. 403
Split-liver transplantation with pediatric donors: a multicenter experience. 402
A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation 402
Totale 43.659
Salva come PNG Salva come JPEG
Categoria #
all - tutte 228.396
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 228.396
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215.888 0 0 0 0 0 1.522 1.715 1.365 311 307 496 172
2021/20222.847 106 305 94 159 79 327 134 123 273 313 123 811
2022/20233.569 377 290 81 371 278 809 327 329 300 23 294 90
2023/20241.322 147 41 189 25 141 308 54 41 35 66 24 251
2024/20258.436 257 1.686 836 488 142 580 595 308 766 716 1.170 892
2025/20266.157 1.043 697 1.350 1.351 1.244 472 0 0 0 0 0 0
Totale 97.270